Women and Lung Cancer: What is New?

Seminars in Thoracic and Cardiovascular Surgery

Volumn 25, Issue 2, 2013, Pages 87-94

  North, Crystal M ^a   Christiani, David C ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Genetic mutations; Lung cancer; Risk factors; Women

Indexed keywords

6 [4 (4 ETHYL 1 PIPERAZINYLMETHYL)PHENYL] 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; BEVACIZUMAB; CANERTINIB; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERLOTINIB; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ETOPOSIDE; GEFITINIB; K RAS PROTEIN; LAPATINIB; MATUZUMAB; PANITUMUMAB; PLATINUM COMPLEX; UNCLASSIFIED DRUG; VANDETANIB; ZD 6476;

ALK GENE; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; EML4 GENE; ENVIRONMENTAL EXPOSURE; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; FAMILY HISTORY; GENE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MUTATIONAL ANALYSIS; ONCOGENE K RAS; ONCOGENE NEU; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; SOMATIC MUTATION; THYROID CANCER; TREATMENT RESPONSE; WART VIRUS;

GENETIC MUTATIONS; LUNG CANCER; RISK FACTORS; WOMEN;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS DISPARITIES; HUMANS; LUNG NEOPLASMS; MALE; PROGNOSIS; RISK FACTORS; SEX FACTORS; SMOKING; WOMEN'S HEALTH;

EID: 84887531250     PISSN: 10430679     EISSN: 15329488     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2013.05.002     Document Type: Article

References (30)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics 2012. CA Cancer J Clin 2012, 62:10-29.
2. Egleston B.L., Meireles S.I., Flieder D.B., et al. Population-based trends in lung cancer incidence in women. Semin Oncol 2009, 36:506-515.
3. Kligerman S., White C. Epidemiology of lung cancer in women: Risk factors, survival, and screening. Am J Roentgenol 2011, 196:287-295.
4. Marshall A.L., Christiani D.C. Genetic susceptibility to lung cancer-light at the end of the tunnel?. Carcinogenesis 2013, 34:487-502.
5. Jemal A., Tiwari R.C., Mirray T., et al. Cancer statistics, 2004. CA Cancer J Clin 2004, 54:8-29.
6. Jemal A., Bray F., Center M.M., et al. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
7. Paulus J.K., Christiani D.C. Environmental Exposures and Cancer, in Women and Health 2012, pp641-pp677. Academic Press, Waltham, MA. ed 2.
8. http://www.who/int/mediacentre/factsheets/fs339/en/index.html.
9. http://www.cdc/gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/.
10. Thun M.J., Carter B.D., Feskanich D., et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013, 368:351-364.
11. Edwards B.K., Brown M.L., Wingo P.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005, 97:1407-1427.
12. Sun S., Schiller J.H., Gazdar A.F. Lung cancer in never smokers-a different disease. Nat Rev Cancer 2007, 7:778-790.
13. Fu J.B., Kau Y., Severson R.K., et al. Lung cancer in women: Analysis of the national surveillance, epidemiology, and end results database. Chest 2005, 127:768-777.
14. Thomas L., Doyle L.A., Edelman M.J. Lung cancer in women: emerging differences in epidemiology, biology, and therapy. Chest 2005, 128:370-381.
15. Bethune G., Bethune D., Ridgway N., et al. Epidermal growth factor receptor (EGFR) in lung cancer: An overview and update. J Thorac Dis 2010, 2:48-51.
16. Hsieh R., Lim K.H., Kuo H.T., et al. Female sex and broncioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer. Chest 2005, 128:317-321.
17. Van Dyke A.L., Cote M.L., Prysak G.M., et al. COX-2/EGFR expression and survival among women with adenocarcinoma of the lung. Carcinogenesis 2008, 29:1781-1787.
18. Yang S., Yang T.Y., Chen K.C., et al. EGFR L858R mutation and polymorphisms of genes related to estrogen biosynthesis and metabolism in never-smoking female lung adenocarcinoma patients. Clin Cancer Res 2011, 17:2149-2158.
19. Berardi R., Verdecchi L., Di Pietro Paolo M., et al. Women and lung cancer: Clinical and molecular profiling as a determinate for treatment decisions: A literature review. Crit Rev Oncol Hematol 2009, 69:223-236.
20. Timofeeva M.N., Hung R.J., Rafnar T., et al. Influence of common genetic variation on lung cancer risk: meta-analysis of 14,900 cases and 24,485 controls. Hum Mol Genet 2012, 21:4980-4995.
21. Li Y., Sheu C.C., Ye Y., et al. Genetic variants and risk of lung cancer in never smokers: A genome-wide association study. Lancet Oncol 2010, 11:321-330.
22. Lan G., Hsiung C.A., Matsuo K., et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet 2012, 44:1330-1335.
23. Huang Y.T., Heist R.S., Chirieac L.R., et al. Genome-wide analysis of survival in early-stage non-small-cell lung cancer. J Clin Oncol 2009, 27:2660-2667.
24. Al-Saad S., Al-Shibli K., Donnem T., et al. Clinical significance of epidermal growth factor receptors in non-small cell lung cancer and a prognostic role for HER2 gene copy number in female patients. J Thorac Oncol 2010, 5:1536-1543.
25. Paulus J.K., Zhou W., Kraft P., et al. Haplotypes of estrogen receptor beta and risk of non-small cell lung cancer in women. Lung Cancer 2011, 71:258-2563.
26. Zhang Y., Yin Z., Shen L., et al. Menstrual factors, reproductive factors and lung cancer risk: A meta-analysis. Chin J Lung Cancer 2012, 15:701-719.
27. Toh C., Ahmad B., Soong R., et al. Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in east-Asian lung adenocarcinomas. J Thorac Oncol 2010, 5:17-22.
28. Heiss G., Wallace R., Anderson G.L., et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. J Am Med Assoc 2008, 299:1036-1045.
29. Li Y., Tsai Y.C., Chen Y.C., et al. Human papilloma virus and female lung adenocarcinoma. Semin Oncol 2009, 36:542-552.
30. Nakamura H., Ando K., Shinmyo T., et al. Female gender is an independent prognostic factor in non-small-cell lung cancer: A meta-analysis. Ann Thorac Cardiovasc Surg 2011, 17:469-480.